Gamma Biosciences is an innovative life sciences platform operating a portfolio of companies that are focused on next-generation bioprocessing technologies for the production of advanced biologic therapies. Created by KKR and other co-investors, Gamma Biosciences is composed of individuals with years of experience in building and sustaining life sciences businesses in the bioprocess and cell & gene therapy spaces.